What's New at AlcheraBio
AlcheraBio CRO Services Expanded to Europe
AlcheraBio is pleased to announce the company’s alliance with Dr. Marie-Paul Lachaud Lefay. AlcheraBio can now conduct and monitor GCP and non-GCP clinical studies in Europe, as well as in the United States. This is particularly convenient for our multinational clients wishing to do approval and/or postmarketing studies on both sides of the Atlantic.
Dr. Lachaud-Lefay assigns a team of local contract monitors in the major European markets on an as-needed basis. European studies are contacted and overseen though our United States headquarters in New Jersey. In addition to monitoring and project management, services available in Europe include: protocol development and case report form (CRF) design; site identification and qualification; data entry and data management using AlcheraBio’s purpose-built double data entry system; statistics; report writing and other technical writing; and assistance with regulatory dossiers. The final product is based on specific clients’ needs, for example, completed cases, locked database, or study report.
To request more information about clinical trial services in Europe, click here.
Spotlight On AlcheraBio
On the Road With AlcheraBio